EQ Labs (Pinksheets: EQLB) $0.08. Today announced its product, EQ Smart Energy Drink®, is undergoing some significant changes. Three new flavors of the effervescent energy tablet have been developed and will soon be introduced; and, the Company is “going green.”
“When you compare the taste of most energy drinks in cans, they all essentially have the same flavor,” stated Mo Owens, EQ Labs, Inc.’s CEO. “Given the fact that our product is different in application, we decided to exploit its uniqueness by providing additional options for consumers,” he said.
“Soon, consumers will find they are not restricted to one single flavor, but instead, a total of 4 choices. There will be the original flavor that has already been widely accepted because of its appealing taste, but soon, they will also be able to choose either strawberry, apple (called Mo’s Apple), and lemon lime,” claimed Owens.
Regarding green packaging, Marvin Cole, EQ Labs, Inc.’s VP of Distribution, commented, “We collaborated with the manufacturers of our packaging to develop individual packets and tubes that are environmentally friendly. Thus, in the near future, all EQ products will be sold in green (biodegradable) packaging. We have always felt some sense of social responsibility, as evidenced by our participation in and sponsorship of charitable events. The green packaging will complement the integrity of the product and convey the message that we are committed to doing our part to promote a healthier environment.”
What They Do: About EQ Labs: EQ Labs (EQLB) manufactures and markets the EQ Smart Energy Drink®, which is an effervescent tablet that provides an instant energy drink once added to any beverage. Consisting of a blend of essential vitamins, including Ginko Bilboa, a single tablet of EQ Smart Energy Drink (containing no sugar and only 5 calories per serving) is the equivalent of one can of any competing energy drink on the market.
EQ is sold in packets of one single tablet or 3-inch tubes of six tablets, which can can be transported in a pocket or purse, and is immediately ready for use. The Company presently distributes its products through national distributors, such as McLane Distributors, which distributes to the national convenience store chain 7- Eleven. Its products can also be found at City Stops and CVS as well as through numerous regional distributors.
To learn more about EQLB visit http://www.smallcapreview.com/eqlb.htm.
China Carbon Graphite Group (OTCBB: CHGI) $0.72. Today announced the introduction of its newly developed fine grain graphite blocks/rods with a length of 3500 mm -- the largest size available in China's carbon market. Thus, China Carbon becomes the first and only Chinese carbon company that produces such large size fine grain graphite.
Fine grain graphite has unique properties of good electric conductivity and heat conductivity, high strength under high temperature, high temperature resistance, corrosion resistance as well as easy machining. It is widely used in the field of monocrystalline silicon, semiconductor technology, precious metal smelting, various molds for continuous casting, diamond sintering as well as cemented carbide sintering. The 3500 mm long fine grain graphite is an ideal material to manufacture large-scale molds. Along with the growing demand for large, highly cosmetic molds, the market demand for high carbon content, large size fine grain graphite is also rapidly growing.
What They Do: China Carbon Graphite Group, through its affiliate, Xingyong Carbon Co., Ltd., manufactures carbon and graphite based products in China.
Cancer Therapeutics (OTCBB: CTHP) $0.41. Announced Wednesday after market close its new partner, NanoTherapies, Inc., is utilizing calcium phosphate nanoparticles to detect and treat cancer. These particles are about 350 times smaller than a human cell while providing both a safe and effective way to transport drugs and imaging materials into diseased cells.
NanoTherapies has sole license and patent protection for the fundamental use of calcium phosphate nanoparticles in medical applications for the treatment and detection of blood cancers (all forms of leukemia). NanoTherapies has all rights to manufacturing technologies and intellectual property required to produce pharmaceutical quality drugs at the scale and yield needed for commercial viability.
What They Do: Cancer Therapeutics, Inc. is a biotechnology business incubator, with a specific emphasis on disruptive treatments and nanotechnology.
About SmallCapReview
Copyright SmallCapReview. SmallCapReview.com has been a leading site for news on small-cap stocks since 1999. SmallCapReview has built a loyal opt-in following for their investor products by providing a newsletter at no cost, sent to subscribers, highlighting select small-cap stocks, to register visit http://www.smallcapreview.com.
SmallCapReview.com is not a registered investment advisor or broker/dealer. No investor should assume that reliance on the views, opinions or recommendations contained herein will produce profitable results. Nothing within our site should be construed as an offer or solicitation to buy or sell products or securities. The companies we profile may lack an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. SmallCapReview.com may hold positions in securities mentioned herein, and may make purchases or sales in such securities featured on our website or within our reports. SmallCapReview has been compensated three thousand five hundred dollars by a third party APS for its efforts in presenting the profile of EQ Labs. SmallCapReview may decide to purchase or sell shares on a voluntary basis in the open market before, during or after the profiling period of this report.
